Creating optimal outcomes for our clients in healthcare leads to stronger, more effective companies, which in turn, helps drive efficiencies and innovation in the healthcare sector.
Patrick provides mergers and acquisitions (M&A) advisory services for healthcare companies. He is focused on executing both sell-side and buy-side transactions in a variety of healthcare subsectors for privately held business and private equity-backed companies.
Patrick understands the dynamics impacting the healthcare sector. As the industry goes through a transition driven by demographic shifts, regulatory changes and technological advances, Patrick assists his clients by effectively positioning their businesses and articulating a unique value proposition to both strategic and private equity buyers. He has experience across a broad range of sectors within the healthcare industry, including clinical lab services, healthcare IT, home healthcare, devices and equipment, products and supplies and third-party administrators.
Prior to joining Lincoln, Patrick worked in the investment banking practice of Allegiance Capital. Previously, he held roles at mid-market investment banks, Livingstone Partners and Lakeshore Food Advisors. He began his career in the insurance industry with roles at Hub International and MetLife.
Patrick earned a Master of Business Administration from the University of Chicago, Booth School of Business and a Bachelor of Arts from the University of Illinois.
Recent Transactions in Healthcare
Lincoln International is pleased to announce the successful sale of C³ (Cannabinoid Compound Company), a subsidiary of Bionorica SE, a producer and marketer of cannabis-based therapeutic compounds, to Canopy Growth
Lincoln International is pleased to have advised Tikehau Capital on its £23 million minority investment into Medtrade, a UK based manufacturer of advanced woundcare and consumer healthcare products
Lincoln International is pleased to announce the successful completion of a $20 million Series C financing round for Rapid Medical
Lincoln International is pleased to announce that Alpha Technics, a Gen Cap America portfolio company, has been sold to TE Connectivity
Lincoln International is pleased to have advised Silverfleet Capital on its agreed acquisition of CARE Fertility from Bowmark Capital
Lincoln International is pleased to announce that it advised Brenntag AG in the sale of Biosector A/S to British specialty chemicals company Croda International plc for a total consideration of Euro 72 million
Lincoln’s Healthcare and TMT groups team to create outlier result for leading Healthcare IT platform
Lincoln International represents Path-Tec, a portfolio company of Fulcrum Equity Partners, in its sale to Lab Logistics, a portfolio company of Atlantic Street Capital